Acute Myeloid Leukemia

---

Overview

Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is characterized by the rapid growth of abnormal myeloid cells, which are a type of white blood cell. These abnormal cells crowd out normal cells, leading to various health issues. AML is more common in adults but can occur at any age.

Symptoms

The symptoms of AML can vary but often include:

• Fatigue and weakness
• Fever and frequent infections
• Easy bruising or bleeding, including nosebleeds and bleeding gums
• Shortness of breath
• Loss of appetite and weight loss
• Bone pain
• Pale skin

These symptoms can arise because the leukemia cells crowd out the healthy blood cells in the bone marrow, leading to anemia, infection, and bleeding problems.

Conventional Treatments

1. Chemotherapy: This is the primary treatment for AML and involves using drugs to kill cancer cells. Treatment is typically divided into two phases:

   • Induction Therapy: Aims to bring about remission. Common drugs include cytarabine and an anthracycline like daunorubicin or idarubicin.
   • Consolidation Therapy: Follows induction to eliminate remaining leukemia cells. High-dose cytarabine is often used.

2. Stem Cell Transplant: Also known as bone marrow transplant, this procedure replaces the diseased bone marrow with healthy cells. It is considered in patients who are at high risk of relapse or do not respond to chemotherapy.

3. Targeted Therapy: Drugs like midostaurin (for those with FLT3 mutations) and enasidenib (for IDH2 mutations) target specific genetic abnormalities in the leukemia cells.

4. Radiation Therapy: Used less frequently, often to treat leukemia that has spread to the brain or to shrink a tumor.

Experimental Treatments

1. Immunotherapy: Includes treatments like monoclonal antibodies and CAR T-cell therapy. These approaches aim to boost the immune system's ability to fight cancer. As of the latest updates, several clinical trials are ongoing.

2. Clinical Trials: Patients can participate in trials testing new drugs, drug combinations, or new approaches to treatment like epigenetic therapies.

Side Effects of Treatments

1. Chemotherapy: Common side effects include nausea, vomiting, hair loss, mouth sores, increased risk of infection, and fatigue. Long-term effects can include heart damage and infertility.

2. Stem Cell Transplant: Can lead to graft-versus-host disease, where the donated cells attack the patient's body, as well as increased risk of infection and organ damage.

3. Targeted Therapy: Side effects vary depending on the drug but can include fatigue, nausea, diarrhea, and liver enzyme abnormalities.

4. Immunotherapy: Potential side effects include flu-like symptoms, rashes, and in severe cases, immune-related adverse events affecting various organs.

Modernity of Treatments

• Chemotherapy and Stem Cell Transplant: These have been the backbone of AML treatment for decades but continue to be refined with newer drug formulations and transplant techniques.

• Targeted Therapy: Midostaurin was approved in 2017, and enasidenib in 2018, marking significant advancements in precision medicine for AML.

• Immunotherapy: This is a rapidly evolving field, with various therapies in clinical trials and some already approved for other cancers. It represents the cutting edge of AML treatment research.

AML treatment is a continually evolving field, with ongoing research seeking to improve outcomes and reduce side effects. Patients are encouraged to discuss all options, including participation in clinical trials, with their healthcare provider.